Methotrexate-induced Oral Mucositis |
Lee, Hye-Jin
(Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty)
Kwon, Jeong-Seung (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) Choi, Young-Chan (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) Ahn, Hyung Joon (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) |
1 | Kremer JM. Toward a better understanding of methotrexate. Arthritis Rheum 2004;50:1370-1382. DOI ScienceOn |
2 | Cipriani P, Ruscitti P, Carubbi F, Liakouli V, Giacomelli R. Methotrexate: an old new drug in autoimmune disease. Expert Rev Clin Immunol 2014;10:1519-1530. DOI ScienceOn |
3 | Czarnecka-Operacz M, Sadowska-Przytocka A. The possibilities and principles of methotrexate treatment of psoriasis: the updated knowledge. Postepy Dermatol Alergol 2014;31:392-400. |
4 | Sakthiswary R, Suresh E. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy. Lupus 2014;23:225-235. DOI ScienceOn |
5 | Bremer JP, Ullrich S, Laudien M, Gross WL, Lamprecht P. Methotrexate plus leflunomide for the treatment of relapsing Wegener's granulomatosis. A retrospective uncontrolled study. Clin Exp Rheumatol 2010;28(1 Suppl 57):67-71. |
6 | Turner D, Doveh E, Cohen A, et al. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study. Gut 2014. doi: 10.1136/gutjnl-2014-307964. [Epub ahead of print] DOI ScienceOn |
7 | Kodama Y, Fukano R, Noguchi M, Okamura J, Inagaki J. Folinic acid after MTX as prophylaxis for GVHD in pediatric bone marrow transplantation. Int J Hematol 2015;101:92-98. DOI ScienceOn |
8 | Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007;65:168-173. |
9 | Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675-2682. DOI ScienceOn |
10 | van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum 1998;27:277-292. DOI ScienceOn |
11 | Bauer J, Fartasch M, Schuler G, Schell H. Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose. Hautarzt 1999;50:670-673. DOI |
12 | Troeltzsch M, von Blohn G, Kriegelstein S, et al. Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:e28-e33. |
13 | Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. Autoimmun Rev 2014;13:1109-1113. DOI ScienceOn |
14 | Park GT, Jeon DW, Roh KH, et al. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency. Korean J Intern Med 1999;14:85-87. DOI |
15 | Kalantzis A, Marshman Z, Falconer DT, Morgan PR, Odell EW. Oral effects of low-dose methotrexate treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:52-62. DOI ScienceOn |
16 | Thumboo J, Koh WH, Leong KH, Boey ML, Feng PH. The safety of weekly low dose oral methotrexate in an Oriental population with rheumatoid arthritis. Ann Acad Med Singapore 1997;26:205-209. |
17 | Shea B, Swinden MV, Tanjong Ghogomu E, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2013;5:CD000951. |
18 | Ranchon F, Vantard N, Gouraud A, et al. Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report: should the practice be changed? Chemotherapy 2011;57:225-229. DOI ScienceOn |
19 | Schnabel A, Gross WL. Low-dose methotrexate in rheumatic diseases:efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 1994;23:310-327. DOI ScienceOn |